article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

The area of medicines development is already a highly regulated space in Europe EFPIA believes that these existing EU legal frameworks, in addition to other regulatory frameworks and policies for medicines set standards to ensure a high level of public health protection.

article thumbnail

Pharma R&D investment report shows positive signs: Deloitte

Outsourcing Pharma

According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

Outsourcing Pharma

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

article thumbnail

Innovation in insulin delivery: Two companies look to transform diabetes treatment

BioPharma Reporter

Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed.